Larry Timlick insider trades: Counterpath (CPAH) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Larry reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 13, 2020 | CPAH | ↓ Sell | 11,000 | $7.08 | $78K | Direct | Jan 14, 2020 (1d) |
| Sep 4, 2015 | CPAH | ↑ Buy | 100,000 | $0.50 | $50K | Direct | Sep 8, 2015 (4d) |
| Aug 20, 2007 | CTPS | ↑ Buy | 50,000 | $0.39 | $20K | Direct | Aug 24, 2007 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Larry Timlick's insider trades
Larry Timlick is a director at Counterpath (CPAH). Since Aug 20, 2007, Larry has reported 2 open-market purchases worth $70K and 1 sale worth $78K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (13 filings), other transactions (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CPAH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.